Publications
- ARTA treatment of metastatic castration-resistant prostate cancer - case report2021 | First Faculty of Medicine
- Strategies sequential treatment of metastatic castration-resistant prostate cancer2020 | First Faculty of Medicine
- Enzalutamide in treatment of the metastatic castrate resistant prostate cancer2019 | First Faculty of Medicine
- The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide2018 | First Faculty of Medicine
- Options of Chemotherapy in the Treatment of Prostate Cancer2017 | First Faculty of Medicine
- Docetaxel-Cabazitaxel-Enzalutamide Versus Docetaxel-Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer2017 | First Faculty of Medicine
- Enzulutamide in treatment in patients with metastatic castration-resistant prostate cancer after previous chemotherapy2017 | First Faculty of Medicine
- Cabazitaxel for the treatment of metastatic castration-resistant prostate cancer2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-resistant Prostate Cancer after Chemotherapy2016 | First Faculty of Medicine
- Klinická onkologie2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
Loading network view...